Record citatie

APA (7e ed.) Bronvermelding
Kokolus, K. M., Zhang, Y., Sivik, J. M., Schmeck, C., Zhu, J., Repasky, E. A., . . . Schell, T. D. (2018). Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice. Taylor & Francis Group.
Chicago (17e ed.) Bronvermelding
Kokolus, Kathleen M., Ying Zhang, Jeffrey M. Sivik, Carla Schmeck, Junjia Zhu, Elizabeth A. Repasky, Joseph J. Drabick, en Todd. D. Schell. Beta Blocker Use Correlates with Better Overall Survival in Metastatic Melanoma Patients and Improves the Efficacy of Immunotherapies in Mice. Taylor & Francis Group, 2018.
MLA (9e ed.) Bronvermelding
Kokolus, Kathleen M., et al. Beta Blocker Use Correlates with Better Overall Survival in Metastatic Melanoma Patients and Improves the Efficacy of Immunotherapies in Mice. Taylor & Francis Group, 2018.
Let op: Deze citaties zijn niet altijd 100% accuraat.